We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDM
251
Piedmont Realty Trust
PDM
$1.18B
$2.3M 0.05%
+316,540
New +$2.11M
FCX icon
252
Freeport-McMoran
FCX
$95.5B
$2.3M 0.05%
+57,393
New +$2.19M
AGEN
253
Agenus
AGEN
$312M
$2.26M 0.05%
70,704
+6,334
+10% +$203K
BDN
254
Brandywine Realty Trust
BDN
$554M
$2.26M 0.05%
+486,115
New +$1.98M
BSX icon
255
Boston Scientific
BSX
$71.4B
$2.24M 0.05%
41,392
-4,616
-10% -$241K
ROKU icon
256
Roku
ROKU
$22.3B
$2.24M 0.05%
35,000
-35,000
-50% -$2.13M
KROS icon
257
Keros Therapeutics
KROS
$211M
$2.22M 0.05%
55,341
+9,857
+22% +$432K
AVTR icon
258
Avantor
AVTR
$8.91B
$2.21M 0.05%
107,470
-6,863
-6% -$139K
FNVT
259
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.2M 0.05%
207,992
-4,689
-2% -$49.3K
BOX icon
260
Box
BOX
$4.41B
$2.2M 0.05%
+75,000
New +$2.08M
DNAD
261
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.19M 0.05%
211,253
-4,761
-2% -$49K
CITE
262
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.18M 0.05%
203,921
-4,597
-2% -$48.8K
MRTX
263
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.16M 0.05%
59,698
+12,448
+26% +$513K
MWA icon
264
Mueller Water Products
MWA
$4.24B
$2.13M 0.05%
+131,500
New +$1.87M
HLN icon
265
Haleon
HLN
$44.2B
$2.13M 0.04%
254,185
+12,523
+5% +$107K
RCUS icon
266
Arcus Biosciences
RCUS
$3.61B
$2.12M 0.04%
104,412
-10,068
-9% -$192K
SPEC
267
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.11M 0.04%
192,601
-6,292
-3% -$68.5K
VERA icon
268
Vera Therapeutics
VERA
$2.3B
$2.05M 0.04%
127,991
-95,477
-43% -$862K
IOVA icon
269
Iovance Biotherapeutics
IOVA
$2.77B
$2.04M 0.04%
289,384
-18,828
-6% -$135K
XME icon
270
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
$2.03M 0.04%
+40,000
New +$1.96M
TCOM icon
271
Trip.com Group
TCOM
$29.1B
$2.01M 0.04%
+57,500
New +$2M
PHAT icon
272
Phathom Pharmaceuticals
PHAT
$679M
$2.01M 0.04%
140,280
+40,187
+40% +$463K
ATRC icon
273
AtriCure
ATRC
$2.01B
$1.99M 0.04%
40,293
-867
-2% -$40K
BCYC
274
Bicycle Therapeutics
BCYC
$278M
$1.99M 0.04%
77,902
-2,817
-3% -$65.4K
IMUX icon
275
Immunic
IMUX
$198M
$1.99M 0.04%
79,169
+10,556
+15% +$177K
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.